Add 2 More Reports For 20% off

Report Overview

The global advanced therapy medicinal products (ATMP) CDMO market was valued at USD 6.14 Billion in 2023, driven by the rising number of clinical trials for ATMPs across the globe. It is expected to grow at a CAGR of 15.30% during the forecast period of 2024-2032, and attain a market value of USD 22.11 Billion by 2032.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

  • In July 2023, the US FDA approved NTLA-2001, the first CRISPR-based gene therapy for treating transthyretin amyloidosis with cardiomyopathy in vivo. Such approvals are expected to boost the demand for CDMO services.
  • In December 2023, the US FDA authorized two gene-based therapies for sickle cell disease. This reflects rapid advancements in gene therapy treatments, which are poised to support market growth in the coming years.
  • Strong regulatory support from health authorities and ongoing research and development efforts are likely to elevate the market value in the forecast period.

Advanced Therapy Medicinal Products (ATMP) CDMO Market Overview

Advanced therapy medicinal products CDMOs specialize in providing innovative cell, gene, and tissue-related treatments such as gene therapies, cell therapies, and tissue-engineered products. They offer a variety of services, including process development, manufacturing, production, and regulatory assistance, to accelerate pharmaceutical companies' entry into the market.

Advanced Therapy Medicinal Products (ATMP) CDMO Market Growth Drivers

Rising Number of Clinical Trials for ATMPs to Drive the Market Growth

The increasing number of clinical trials is fueling market growth, with 3,579 therapies in development by Q1 2022, led by CAR-T cell treatments. The gene cell therapy pipeline has increased by 16% since the first quarter of 2021, with 98% of CAR-T cell treatments in the development phase for cancer indications.

Advanced Therapy Medicinal Products (ATMP) CDMO Market Trends

Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

  • Cell Therapy
  • Gene Therapy
  • Others

Market Breakup by Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Market Breakup by Indication

  • Neurology
  • Cariology
  • Oncology
  • Ophthalmology
  • Dermatology
  • Immunology
  • Others

Market Breakup by Region

  • North America 
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Advanced Therapy Medicinal Products (ATMP) CDMO Market Share

Market Segmentation Based on the Product to Witness Growth

Based on the product, the market is divided into cell therapy, gene therapy, and others. The gene therapy sector is leading because of substantial funding, robust clinical trial activity, and a variety of therapies being developed for diseases such as neurological, cancer, cardiovascular, blood, and infectious diseases.

Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis by Region

The market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to lead the market share in the forecast period owing to the rising popularity of outsourcing services and growing awareness of advanced therapies.

Leading Players in the Advanced Therapy Medicinal Products (ATMP) CDMO Market

The key features of the market report include patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Rentschler Biopharma SE

Rentschler Biopharma is a contract development and manufacturing organization (CDMO) that is actively engaged in developing and producing biopharmaceuticals. In September 2024, a new lentiviral vector manufacturing toolbox for advanced therapies was launched by the CDMO in the UK. This package comprises process development, cGMP manufacturing, and regulatory assistance.

AGC Biologics

AGC Biologics provides various cell therapy options for advanced therapy medicinal products (ATMPs), such as g...

Celonic Group

Celonic Group provides development and manufacturing services for new biological entities, biosimilars, cell t...

Bio Elpida

Bio Elpida, a Biotechnology contract manufacturing company in Lyon, France, specializes in advanced therapy me...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other players in the market are Cell Therapy Catapult Ltd., Catalent, Inc., Lonza, WuXi Advanced Therapies, and Minaris Regenerative Medicine.

Key Questions Answered in the Advanced Therapy Medicinal Products (ATMP) CDMO Market Report

  • What was the advanced therapy medicinal products (ATMP) CDMO market value in 2023?
  • What is the advanced therapy medicinal products (ATMP) CDMO market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is the market segmentation based on the product?
  • What is the market segmentation based on the phase?
  • What is the market breakup based on indication?
  • What are the major factors aiding the advanced therapy medicinal products (ATMP) CDMO market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major drivers, opportunities, and restraints in the market?
  • What are the major trends influencing the market?
  • Which regional market is expected to dominate the market share in the forecast period?
  • Which country is likely to experience elevated growth during the forecast period?
  • Who are the key players involved in the advanced therapy medicinal products (ATMP) CDMO market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Phase
  • Indication
  • Region
Breakup by Product
  • Cell Therapy
  • Gene Therapy
  • Others
Breakup by Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Breakup by Indication
  • Neurology
  • Cariology
  • Oncology
  • Ophthalmology
  • Dermatology
  • Immunology
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Celonic Group
  • Bio Elpida
  • Cell Therapy Catapult Ltd.
  • Rentschler Biopharma SE
  • AGC Biologics
  • Catalent, Inc
  • Lonza
  • WuXi Advanced Therapies
  • Minaris Regenerative Medicine

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124